SCHEMBL8624255

SCHEMBL8624255

CCOP(=O)(OCC)C(CCCc1cccc(Oc2ccccc2)c1)S(=O)(=O)O

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 13/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8624038 0.90 FDFT1 (0.57) FDFT1
SCHEMBL8619968 0.87 POLB (0.47) FDFT1
SCHEMBL8619897 0.87 FDFT1 (0.54) FDFT1
SCHEMBL8621227 0.85 FDFT1 (0.67) FDFT1
SCHEMBL8619815 0.85 FDFT1 (0.67) FDFT1
SCHEMBL1538945 0.85 FDFT1 (0.67) FDFT1
SCHEMBL8625395 0.85 POLB (0.44) FDFT1
SCHEMBL8824807 0.84 FDFT1 (0.53) FDFT1
SCHEMBL762953 0.84 FDFT1 (0.53) FDFT1
SCHEMBL413233 0.84 FDFT1 (0.65) FDFT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed
EP-0595635-A1 Alpha-phosphorous substituted sulfonate derivatives as squalene synthetase inhibitors E.R. Squibb & Sons, Inc. (US) 1994-05-04 EP disclosed